Abstract:OBJECTIVE:To investigate the effect on cell proliferation and chemosensitivity of human pancreatic cancer cells Panc-1 after X-linked inhibitor of apoptosis protein (XIAP) and Survivin are inhibited simultaneously, and to compare it with the separate gene suppression strategy by which expression of XIAP or Survivin is inhibited respectively.METHODS:Panc-1 (Panc-1-X, Panc-1-S and Panc-1-XS) in which expression of XIAP and/or Survivin was inhibited, was established by using XIAP-shRNA lentiviral and Survivin-shRNA lentiviral we had built. The expressions of XIAP and Survivin mRNA and protein were evaluated by Real-time PCR and Semi-quantitatively Western blot analysis; cell proliferation was investigated by cell counting and colony formation assay; cell apoptosis was investigated by Caspase-3/7 activity assay kit and flow cytometry; gemcitabine (Gem) chemosensitivity was investigated by MTT assay.RESULTS:The pancreatic cell line Panc-1 in which the expression of XIAP and/or Survivin was stablely inhibited was successfully established. The cell proliferation of Panc-1-XS cells decreased significantly. The colony formation rate of Panc-1-XS cells (10.12%± 1.33%), was significantly lower than that of Panc-1-XncSnc cells (96.61% ± 7.89%) and Panc-1 cells (100.28% ± 8.97%) respectively (P<0.05). After being treated by 0.5 mg/L Gem for 24 h, the Caspase-3/7 relative activity of Panc-1-XS cells (15.02 ± 0.57) was significantly higher than that of Panc-1 cells and Panc-1-XncSnc cells (8.87 ± 0.19 and 9.05 ± 0.23, respectively; P<0.05); and the rate of apoptosis of Panc-1-XS cells (24.09% ± 2.75%) was significantly higher than that of Panc-1-XncSnc cells and Panc-1 cells (12.09% ± 1.97% and 12.06% ± 1.22%, respectively; P<0.05). The IC50 value of Panc-1-XS cells [(0.47 ± 0.04) mg/L] was significantly lower than that of Panc-1-XncSnc cells [(2.18 ± 0.13) mg/L] and Panc-1 cells [(2.13 ± 0.18) mg/L, P<0.05]. Further testing also showed that, the IC50 value of Panc-1-XS cells [(0.47 ± 0.04) mg/L] was significantly lower than that of Panc-1-X cells [(0.76 ± 0.07) mg/L] and Panc-1-S cells [(0.87 ± 0.09) mg/L, P<0.05].CONCLUSION:The cell proliferation of Panc-1 cells was significantly suppressed and the Gem chemosensitivity was significantly enhanced after expressions of XIAP and Survivin were inhibited simultaneously, and significantly better than the strategy in which expressions of XIAP and Survivin were inhibited separately.

Inhibitor of XIAP Embelin Reverses the Resistance of Human Pancreatic Carcinoma Patu8988 Cell Line to Pemetrexed

X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells.

Anti-tumor Activity of Emodin on Human Pancreatic Cancer Cell Line BXPC-3 in Vivo

Anti-tumor Activity of the X-linked Inhibitor of Apoptosis (XIAP) Inhibitor Embelin in Gastric Cancer Cells

Synergistic Effects of TOR Combined with EADM on Growth and Apoptosis in Human Lung Cancer Cell Lines A549 and H1299

Peroxisome Proliferator-Activated Receptor-Gamma Contributes to the Inhibitory Effects of Embelin on Colon Carcinogenesis

Embelin Inhibits Pancreatic Cancer Progression by Directly Inducing Cancer Cell Apoptosis and Indirectly Restricting IL-6 Associated Inflammatory and Immune Suppressive Cells11these Authors Contributed Equally to This Work.

Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells.

Combined Application of Embelin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Proliferation and Invasion in Osteosarcoma Cells Via Caspase-Induced Apoptosis

Expression of XIAP in Pancreatic Carcinoma Cell Line BxPC-3 Induced by Gemcitabine

Simultaneous Silencing of XIAP and Survivin Causes Partial Mesenchymal-Epithelial Transition of Human Pancreatic Cancer Cells Via the PTEN/PI3K/Akt Pathway

Discovery of Embelin As a Cell-Permeable, Small-Molecular Weight Inhibitor of XIAP Through Structure-Based Computational Screening of a Traditional Herbal Medicine Three-Dimensional Structure Database

Targeting X-linked Inhibitor of Apoptosis Protein Inhibits Pancreatic Cancer Cell Growth Through P-Akt Depletion.

The effects of cetuximab in combination with docetaxel for the acquired resistance to EGFR-TKI in non-small cell lung cancer cells

The XIAP inhibitor Embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation

Influence of Stable Inhibition of XIAP and Survivin Expression on Biological Characteristics of Pancreatic Cancer Cells

Reversal Effect of Recombinant Human Endostatin on Cisplatin Resistance Line A549/DDP Human Lung Adenocarcinoma Cells

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway

[X-Linked Inhibitor of Apoptosis Protein (XIAP) and Survivin Suppression on Human Pancreatic Cancer Cells Panc-1 Proliferation and Chemosensitivety].

Abnormal Expression of PTEN and PIK3CA in Pemetrexed-Resistant Human Pancreatic Cancer Cell Line Patu8988.

Research on the cloning capability,invasion and associated resistance genes of Patu8988 pancreatic cancer cells resistance to the pemetrexed